Compare MYSE & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYSE | BFRG |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Retail: Computer Software & Peripheral Equipment |
| Sector | Telecommunications | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 10.4M |
| IPO Year | 2021 | 2023 |
| Metric | MYSE | BFRG |
|---|---|---|
| Price | $2.65 | $1.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 53.6K | ★ 69.1K |
| Earning Date | 11-13-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $581.00 | ★ $116,670.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.82 | N/A |
| 52 Week Low | $1.61 | $0.80 |
| 52 Week High | $9.34 | $4.84 |
| Indicator | MYSE | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 63.54 | 57.48 |
| Support Level | $2.30 | $1.10 |
| Resistance Level | $2.72 | $1.20 |
| Average True Range (ATR) | 0.21 | 0.08 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 93.58 | 92.43 |
Myseum Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.